Life Sciences / Companies

Ridgeback Capital

Ridgeback Capital is an actively managed private investment company, founded in 2006 by Wayne Holman, MD, that specializes in securities trading and long-term private investment with a focused emphasis on investing in life science and biopharma companies. The firm provides patient capital to private and public healthcare companies and states a goal of supporting innovators developing life-saving and life-changing technologies.

Industries

biotechnology
finance
financial-services

Nr. of Employees

small (1-50)

Ridgeback Capital

348 West 14th Street, New York, NY, 10014

Portfolio

Adaptimmune

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

Cellectis

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

FibroGen

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

MacroGenics

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

Sangamo

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

Ironwood Pharmaceuticals

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.